SER
Serina Therapeutics·AMEX
--
--(--)
--
--(--)
SER fundamentals
Serina Therapeutics (SER) released its earnings on Aug 11, 2025: revenue was 130.00K (YoY --), beat estimates; EPS was -0.66 (YoY --), missed estimates.
Revenue / YoY
130.00K
--
EPS / YoY
-0.66
--
Report date
Aug 11, 2025
EPS
Actual | -0.49 | -0.66 | |||||||||||||||||||||||||
Forecast | -0.62 | -0.425 | |||||||||||||||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +20.97% | -55.29% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 130.00K |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Serina Therapeutics's earnings call?What is Serina Therapeutics's latest dividend and current dividend yield?Did Serina Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Serina Therapeutics next quarter?What does Serina Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Serina Therapeutics year over year?What were the key takeaways from Serina Therapeutics’s earnings call?What is Serina Therapeutics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
